We are live on
!
Find out more
IC
IEQ Capital Portfolio holdings
AUM
$21.5B
1-Year Est. Return
75.26%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
+$644M
(+15%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$47.1M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$47M |
| 3 |
Roblox
RBLX
|
+$27.7M |
| 4 |
Joby Aviation
JOBY
|
+$15.4M |
| 5 |
Apple
AAPL
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$12.8M |
| 2 |
CrowdStrike
CRWD
|
+$9.9M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$7.59M |
| 4 |
Silicon Laboratories
SLAB
|
+$7.54M |
| 5 |
Penumbra
PEN
|
+$7.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Communication Services | 13.07% |
| 3 | Consumer Discretionary | 6.86% |
| 4 | Healthcare | 6.72% |
| 5 | Financials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.64B
| $324K | 0.01% |
12,317
| – | – |
|
652
Quest Diagnostics
DGX
$25.8B
| $321K | 0.01% |
2,282
+302
| +15% | +$41.6K |
|
653
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
| $319K | 0.01% |
+4,799
| New | +$320K |
|
|
P
654
Everpure Inc
P
$27.9B
| $319K | 0.01% |
8,655
-2,872
| -25% | -$81.4K |
|
655
iShares US Treasury Bond ETF
GOVT
$43.6B
| $319K | 0.01% |
13,909
-714
| -5% | -$16.6K |
|
656
Akamai
AKAM
$17.9B
| $318K | 0.01% |
+3,541
| New | +$303K |
|
657
Weyerhaeuser
WY
$18.6B
| $318K | 0.01% |
9,492
-5,058
| -35% | -$152K |
|
658
C.H. Robinson
CHRW
$18.1B
| $318K | 0.01% |
3,368
-1,507
| -31% | -$146K |
|
659
Fortune Brands Innovations
FBIN
$6.29B
| $316K | 0.01% |
4,399
-348
| -7% | -$22.1K |
|
660
LPL Financial
LPLA
$27.9B
| $316K | 0.01% |
1,455
-468
| -24% | -$93.7K |
|
661
CF Industries
CF
$18.1B
| $316K | 0.01% |
4,555
-1,789
| -28% | -$125K |
|
662
Principal Financial Group
PFG
$24.7B
| $314K | 0.01% |
4,145
-1,536
| -27% | -$111K |
|
|
MDC
663
DELISTED
M.D.C. Holdings, Inc.
MDC
| $313K | 0.01% |
6,692
-443
| -6% | -$18.4K |
|
664
TotalEnergies
TTE
$189B
| $313K | 0.01% |
5,427
-702
| -11% | -$42.5K |
|
665
Incyte
INCY
$24.4B
| $313K | 0.01% |
5,025
-3,166
| -39% | -$212K |
|
|
GRMN
666
Garmin
GRMN
$59.3B
| $311K | 0.01% |
2,985
-938
| -24% | -$95.8K |
|
667
Dimensional US Marketwide Value ETF
DFUV
$15.7B
| $310K | 0.01% |
8,996
| – | – |
|
668
Fiverr
FVRR
$347M
| $310K | 0.01% |
11,900
+20
| +0.2% | +$603 |
|
669
iShares MSCI India ETF
INDA
$6.65B
| $309K | 0.01% |
7,079
+262
| +4% | +$10.9K |
|
|
DAY
670
DELISTED
Dayforce
DAY
| $309K | 0.01% |
4,613
-1,804
| -28% | -$116K |
|
671
LiveRamp
RAMP
$2.3B
| $308K | 0.01% |
10,782
| – | – |
|
672
iShares US Healthcare ETF
IYH
$3.45B
| $306K | 0.01% |
+5,460
| New | +$303K |
|
673
Newell Brands
NWL
$2.61B
| $306K | 0.01% |
+35,176
| New | +$350K |
|
|
SCHR
674
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $304K | 0.01% |
12,334
+20
| +0.2% | +$501 |
|
675
Brown-Forman Class B
BF.B
$13.1B
| $304K | 0.01% |
4,550
-2,350
| -34% | -$150K |
|
Similar funds
DSA
MMH
AM
VARA
SC
BA
IEQ Capital's Q2 2023 Portfolio in Review
As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.
- IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
- IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
- IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
- IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
- IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
- IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
- IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.
Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.